What is Novosound?
Novosound Health is a specialized health-tech enterprise focused on the development of innovative, cuffless blood pressure monitoring solutions. Its core product, senseBP, utilizes patented ultrasound technology to deliver accurate, comfortable, and calibration-free readings suitable for both clinical and home-based environments. By targeting the massive global demographic affected by hypertension, Novosound is effectively bridging the gap between professional-grade diagnostic accuracy and consumer-friendly usability. The company's market position is defined by its commitment to high-precision engineering and its ability to scale health-monitoring hardware within the competitive digital health landscape.
How much funding has Novosound raised?
Novosound has raised a total of $10.7M across 4 funding rounds:
Angel/Seed
$1.1M
Unspecified
$2.7M
Unspecified
$4.4M
Unspecified
$2.6M
Angel/Seed (2018): $1.1M, investors not publicly disclosed
Unspecified (2019): $2.7M led by European Regional Development Fund, The Foresight Williams Technology EIS Fund, and Foresight Scottish Growth Fund
Unspecified (2019): $4.4M supported by The Foresight Williams Technology EIS Fund, Scottish Investment Bank, Kelvin Capital, Gabriel Investments, Foresight Scottish Growth Fund, University of the West of Scotland, and Par Equity
Unspecified (2024): $2.6M featuring Par Equity, Kelvin Capital, and University of the West of Scotland
Key Investors in Novosound
Par Equity
Par Equity is a venture capital firm based in Edinburgh and Leeds, specializing in investing in innovative, high-growth technology companies from Seed to Series A.
Kelvin Capital
Kelvin Capital specializes in venture capital investments in revenue-generating growth companies with high return potential, leveraging a wide network of UK-based syndicate partners.
Scottish Investment Bank
The Scottish Investment Bank is a national economic development agency and a non-departmental public body of the Scottish Government focused on fostering regional economic growth.
What's next for Novosound?
Looking ahead, Novosound is poised to transition from its current development phase into a broader commercial expansion strategy. The recent influx of capital will likely be deployed to scale manufacturing operations, enhance supply chain resilience, and expand market penetration across international health sectors. As the demand for remote patient monitoring and preventative health technologies continues to rise, Novosound's focus on non-invasive, reliable diagnostic tools provides a clear competitive advantage. Strategic priorities will likely include deepening clinical validation studies and forging partnerships with healthcare providers to integrate senseBP into standard patient care workflows, ultimately aiming to improve long-term health outcomes for millions of users worldwide.
See full Novosound company page
